| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H28N2O2 |
| Molecular Weight | 340.4592 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2CC)[C@H](O)C3=C4C=C(OCC)C=CC4=NC=C3
InChI
InChIKey=SUWZHLCNFQWNPE-LATRNWQMSA-N
InChI=1S/C21H28N2O2/c1-3-14-13-23-10-8-15(14)11-20(23)21(24)17-7-9-22-19-6-5-16(25-4-2)12-18(17)19/h5-7,9,12,14-15,20-21,24H,3-4,8,10-11,13H2,1-2H3/t14-,15-,20-,21+/m0/s1
| Molecular Formula | C21H28N2O2 |
| Molecular Weight | 340.4592 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ethylhydrocupreine Hydrochloride (optochin) is a reagent used in the alteration in bacterial morphology, it is now used in cell culture techniques for the presumptive identification of Streptococcus pneumoniae, which is optochin-sensitive, from other alpha-hemolytic streptococci such as viridans streptococci, which are resistant. However, a single standardized procedure does not exist. Optochin is included neither in the current EUCAST breakpoint tables nor in the CLSI performance standards for antimicrobial susceptibility testing.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
Patents
Sample Use Guides
in mice: The ethylhydrocuprein (optochin base) was administered in the form of a 2 per cent solution in olive oil, given under the skin of the back. This treatment was given, in the first instance, immediately after the infection; if a second dose was given it was given after an interval of 24 hours
Route of Administration:
Other
|
|
SALT/SOLVATE -> PARENT |
Showing 1 to 1 of 1 entries